Eric Topol/LinkedIn
May 31, 2026, 15:41
Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
Eric Topol, Founder and Director of Scripps Research Translational Institute, shared a post on X about a recent article by Xiaqing Jiang et al., published in The Lancet, adding:
”The p-tau217 breakthrough blood test replicated again, predicting Alzheimer’s disease in a large cohort mean age 61.
The cover of the new issue is telling.”
Title: Alzheimer’s disease neuropathology plasma biomarkers and cognition in midlife: a community-based cohort study
Authors: Xiaqing Jiang, Tina D Hoang, Prof Leslie M Shaw, Prof David R Jacobs, Ilya M Nasrallah, Prof R Nick Bryan, Prof Kristine Yaffe
Other posts featuring Eric Topol on Hemostasis Today.
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH
-
Oct 16, 2026, 10:07Habib Bennaceur: Building a Stronger Care Pathway for Sickle Cell Disease in India
-
Oct 16, 2026, 09:59Tareq Abadl: A Simple Guide to Blood Collection Tubes
-
Oct 16, 2026, 09:50Mona Alfaraj: Distinguishing HCL from SMZL in Bone Marrow